Podcast

Robert S. Rosenson, MD, on Secondary Prevention of ASCVD

03/10/2020

 

In this podcast, Robert S. Rosenson, MD, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and the implications of the research for clinical practice.

Robert S. Rosenson, MD, is a professor of medicine at Mount Sinai Heart at the Icahn School of Medicine at Mount Sinai in New York, New York. He is also the section editor of Lipid and Metabolic Disorders at the Journal of the American College of Cardiology and section editor of Lipid Disorders for Up to Date Medicine.

Additional Resources:

  • Colantonio LD, Shannon ED, Orroth KK, et al. Ischemic event rates in very-high-risk adults. J Am Coll Cardiol. 2019;74(20):2496-2507. https://doi.org/10.1016/j.jacc.2019.09.025.
  • Bittner V, Colantonio LD, Dai Y, et al. Association of region and hospital and patient characteristics with use of high-intensity statins after myocardial infarction among Medicare beneficiaries. JAMA Cardiol. 2019;4(9):865-872. https://doi.org/10.1001/jamacardio.2019.2481.
  • Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;73(24):e285-e350. https://doi.org/10.1016/j.jacc.2018.11.003. 
  • Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01764633. Published February 15, 2018. Updated August 21, 2019. Accessed February 7, 2020. ClinicalTrials.gov Identifier: NCT01764633.
  • ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01663402. Published March 18, 2019. Updated March 18, 2019. Accessed February 7, 2020. ClinicalTrials.gov Identifier: NCT01663402.
  • Mach F, Baigent C, Catapano AL, et al; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455. 
  • IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00202878. Published September 30, 2015. Updated September 21, 2018. Accessed February 7, 2020. ClinicalTrials.gov Identifier: NCT00202878. 
  • Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, et al; AKCEA-APO(a)-LRX Study Investigators. New Engl J Med. 2020;382(3):244-255. https://doi.org/10.1056/nejmoa1905239. 

Related Content

Neurology
Neurology
Expert Conversations: Bioluminescence in Brain Cells
06/04/2019
Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their...
06/04/2019
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Mardi Gomberg-Maitland, MD, MSc, on Right Heart Catheterization in the Management of Patients With PH
05/18/2015
In this podcast, Mardi Gomberg-Maitland, MD, MSc, speaks about the reasons she believes right heart catheterization is necessary in the follow-up management of patients with pulmonary hypertension,...
05/18/2015
Stress and Burnout
Stress and Burnout
Sarah Piraino, PharmD, on Diabetes and COVID-19
10/27/2011
In this podcast, Sarah Piraino, PharmD, speaks about glycemic outcomes in people with diabetes in the presence or absence of COVID-19 infection, including gaps that exist in the research and future...
10/27/2011
Inflammatory Bowel Disease
Inflammatory Bowel Disease
David Hudesman, MD, on IBD Management and Prevention of Infection
09/19/2018
Dr David Hudesman from NYU Langone discusses the challenges associated with treating patients with inflammatory bowel disease, a topic in which he will be presenting at IBD Clinical Challenges and Emerging...
09/19/2018
Cardiovascular Diseases
Cardiovascular Diseases
Andrew Freeman, MD, on Weeding Out the Food Trends for CV Health
09/05/2018
Dr Andrew Freeman from National Jewish Health discusses his latest research: "A Clinician's Guide for Trending Cardiovascular Nutrition Controversies," which was recently published in JACC.
09/05/2018